An interventional pilot study protocol on the effect of extra virgin olive oil on women with preeclampsia risk.
Yaniv S Ovadia, Daniela Abigail Navarro, Avi Rimler...
https://pubmed.ncbi.nlm.nih.gov/41835790/Actively Recruiting
Led by Yaniv Ovadia · Updated on 2025-02-06
156
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating the potential benefits of Extra Virgin Olive Oil from early harvested olives EVOOEH in lowering the risk of preeclampsia PE among pregnant women at high risk. This study focuses on how the antioxidant-rich EVOOEH may improve blood vessel health, reduce oxidative stress, and prevent complications such as PE and gestational diabetes mellitus GDM. The trial is interventional and randomized, involving 156 pregnant women aged 18 to 45 who have risk factors for PE. Participants are divided into two groups one group consumes 42 ml three tablespoons of EVOOEH daily along with the Ministry of Health MOH dietary recommendations for pregnancy for four weeks, starting between 8 and 16 weeks of gestation. The control group follows only the MOH dietary recommendations for the same period. Both groups receive low-dose aspirin as a preventive measure against PE. The study monitors adherence to a Mediterranean diet and measures hydroxytyrosol levels in blood as markers of compliance. During the study, participants will undergo blood tests to measure glucose challenge test results and the sFlt-1PlGF ratio after four weeks of intervention. Researchers will also review pregnancy outcomes including rates of PE, GDM, cesarean sections, preterm births, and small for gestational age babies. Blood pressure and gestational age at delivery will be monitored, and data from medical records will be collected. Laboratory analyses will be performed at specialized centers to assess key biomarkers. The total study duration includes the four weeks of intervention and follow-up until delivery to evaluate outcomes.
CONDITIONS
An Interventional Pilot Study on the Effect of Extra Virgin Olive Oil on Women with Preeclampsia Risk
Y
Yaniv Dr Yaniv S. Ovadia, RD PhD
A
Arie Dr Arie Budovsky, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Yaniv Ovadia
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 4 weeks
Participants follow dietary recommendations for pregnancy with or without the addition of 42 ml (three tablespoons) of extra virgin olive oil each morning for four weeks during early pregnancy (gestational ages between 8 to 16 weeks).
1 baseline visit and 1 follow-up visit
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Yaniv S Ovadia, Daniela Abigail Navarro, Avi Rimler...
https://pubmed.ncbi.nlm.nih.gov/41835790/Yaniv Ovadia
Lead Sponsor